Challenges and innovations in patient selection, biomarkers, and personalized treatments within the I-O landscape

Lauren Coyle, Commissioning Editor of Immuno-Oncology Insights, speaks with Oliver Rosen, Chief Medical Officer of Akamis Bio, to discuss the impact of accurate patient selection on the effectiveness of I-O treatments and the limitations of current biomarkers in patient selection.

Please enter your email to access content Read now